Literature DB >> 16110075

Need for differential discounting of costs and health effects in cost effectiveness analyses.

Werner B F Brouwer1, Louis W Niessen, Maarten J Postma, Frans F H Rutten.   

Abstract

Mesh：

Year:  2005        PMID： 16110075      PMCID： PMC1188116          DOI： 10.1136/bmj.331.7514.446

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  13 in total

Review 1.  Economic notes. Discounting.

Authors:  D J Torgerson; J Raftery
Journal:  BMJ       Date:  1999-10-02

2.  A fair approach to discounting future effects: taking a societal perspective.

Authors:  W Brouwer; B van Hout; F Rutten
Journal:  J Health Serv Res Policy       Date:  2000-04

3.  Discounting for health effects in cost-benefit and cost-effectiveness analysis.

Authors:  H Gravelle; D Smith
Journal:  Health Econ       Date:  2001-10       Impact factor: 3.046

4.  Discounting and health benefits.

Authors:  M Parsonage; H Neuburger
Journal:  Health Econ       Date:  1992-04       Impact factor: 3.046

5.  Discounting costs and effects: a reconsideration.

Authors:  B A van Hout
Journal:  Health Econ       Date:  1998-11       Impact factor: 3.046

6.  Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party.

Authors:  M F Drummond; T O Jefferson
Journal:  BMJ       Date:  1996-08-03

7.  Foundations of cost-effectiveness analysis for health and medical practices.

Authors:  M C Weinstein; W B Stason
Journal:  N Engl J Med       Date:  1977-03-31       Impact factor: 91.245

8.  Implementing intensive control of blood glucose concentration and blood pressure in type 2 diabetes in England: cost analysis (UKPDS 63).

Authors:  Alastair Gray; Philip Clarke; Andrew Farmer; Rury Holman
Journal:  BMJ       Date:  2002-10-19

9.  Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. UK Prospective Diabetes Study Group.

Authors: 
Journal:  BMJ       Date:  1998-09-12

10.  Modelling cost effectiveness of meningococcal serogroup C conjugate vaccination campaign in England and Wales.

Authors:  Caroline L Trotter; W John Edmunds
Journal:  BMJ       Date:  2002-04-06
View more
  52 in total

1.  Effect of discounting on estimation of benefits determined by hepatitis C treatment.

Authors:  Andrea Messori; Valeria Fadda; Dario Maratea; Sabrina Trippoli
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

2.  Perspective and desire in comparative effectiveness research: the relative unimportance of mere preferences, the central importance of context.

Authors:  Anthony J Culyer
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

3.  Towards a social discount rate for the economic evaluation of health technologies in Germany: an exploratory analysis.

Authors:  Mareike Schad; Jürgen John
Journal:  Eur J Health Econ       Date:  2010-12-19

Review 4.  Should universal hepatitis B immunisation be introduced in the UK?

Authors:  P English
Journal:  Arch Dis Child       Date:  2006-04       Impact factor: 3.791

5.  Distribution-Weighted Cost-Effectiveness Analysis Using Lifetime Health Loss.

Authors:  Ulrikke J V Hernæs; Kjell A Johansson; Trygve Ottersen; Ole F Norheim
Journal:  Pharmacoeconomics       Date:  2017-09       Impact factor: 4.981

6.  Differential time preferences for money and quality of life.

Authors:  M B Y Parouty; H H Le; D Krooshof; M J Postma
Journal:  Pharmacoeconomics       Date:  2014-04       Impact factor: 4.981

7.  A health economic model for evaluating a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in the UK.

Authors:  Lee Moore; Vanessa Remy; Monique Martin; Maud Beillat; Alistair McGuire
Journal:  Cost Eff Resour Alloc       Date:  2010-04-30

8.  Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study.

Authors: 
Journal:  BMJ       Date:  2009-07-28

9.  Cost-effectiveness of the diabetes care protocol, a multifaceted computerized decision support diabetes management intervention that reduces cardiovascular risk.

Authors:  Frits G W Cleveringa; Paco M J Welsing; Maureen van den Donk; Kees J Gorter; Louis W Niessen; Guy E H M Rutten; William K Redekop
Journal:  Diabetes Care       Date:  2009-11-23       Impact factor: 19.112

Review 10.  Health economic assessment: a methodological primer.

Authors:  Steven Simoens
Journal:  Int J Environ Res Public Health       Date:  2009-11-27       Impact factor: 3.390
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.